11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...

11/25/2025Luye Pharma Receives FDA IND Clearance for LY03017

11/25/2025Huaota Reports Pivotal Phase 3 Success for HB0017

11/25/2025Pfizer's Hympavzi (Marstacimab) Gains NMPA Approval in China

11/21/2025CSPC Advances Nectin-4 ADC SYS6002 Into First Phase 3 Trial

11/21/2025Lynk Reports Positive Phase II Results for Topical JAK Inhibitor

11/21/2025Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...

11/20/2025Innovent's Mazdutide Achieves Strong Phase 3 Results in Chinese Obesit...

11/19/2025China Accelerates Animal Testing in Ambitious Biotech Push

11/18/2025Roche's Subcutaneous PD-L1 Therapy Wins China Approval

11/18/2025Sinovac Expands Flu Vaccine Use to Infants from 6 Months

11/18/2025Qilu to Share First-in-Human Data of Trispecific Antibody QLS4131 at A...

11/18/2025Akeso's First CNS Candidate Cleared for Alzheimer's Clinical Trials in...

11/18/2025Henlius and Organon Score First Interchangeable Biosimilar to Perjeta

11/14/2025NMPA Clears IND for GenSci's In-House Bispecific ADC GenSci140

11/13/2025GenFleet Registers First Phase 3 Trial of KRAS G12D Inhibitor GFH375 i...

11/11/2025Zydus Receives China NMPA Approval for Venlafaxine ER Capsules

11/11/2025Glenmark Gains NMPA Approval for RYALTRIS®

11/11/20253SBio Presents Encouraging Phase 2 Results for SSGJ‑707 at SITC 2025

11/11/2025China Approves CPEB's Pediatric CAR‑T Therapy for r/r B‑ALL

11/11/2025Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...

11/11/2025Innovent and SanegeneBio Present Positive Phase 1 Data for siRNA Thera...

11/11/2025Huahui to Present 48-Week Phase 2b Data of Libevitug at AASLD 2025

11/7/2025Lepu to Present Promising Phase II Data of CD20 ADC MRG001 Plus Orelab...

11/7/2025CARsgen Reports Positive Results for Allogeneic CAR-T Therapies CT0596...

11/7/2025Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...

11/7/2025Correctseq Reports World's First Gene-Editing Treatment for Hyperlipid...

11/6/2025China Grants Conditional Approval for ACEA's COVID-19 Antiviral Olgotr...

11/6/2025Novartis Wins China Approval for Two Pluvicto Indications

11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval

Page:1/20 Total number of articles:596: [First][<<] [1] [2] [3] [4] [5] [>>] [End]